Author(s): Abraham JM, Cho L
Abstract Share this page
Abstract Although evidence suggests that the homocysteine hypothesis is still relevant as a predictor of cardiovascular risk, we cannot conclude that measuring the homocysteine level is useful in guiding treatment. Furthermore, studies of primary and secondary prevention show no evidence that taking folic acid or other B vitamins lowers the risk of cardiovascular events.
This article was published in Cleve Clin J Med
and referenced in Journal of Diabetes & Metabolism